Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Reflux esophagitis].

I Schiefke1, J Mössner, K Caca

  • 1Medizinische Klinik und Poliklinik II, Universität Leipzig.

Der Internist
|February 9, 2005
PubMed
Summary
This summary is machine-generated.

Gastroesophageal reflux disease (GERD) affects millions, with proton pump inhibitors (PPIs) and surgery as main treatments. Endoscopic therapies offer a potential third option, but long-term data is needed to identify suitable candidates.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of sex on the efficacy and safety of panitumumab plus fluorouracil and folinic acid versus fluorouracil and folinic acid alone as maintenance therapy in RAS WT metastatic colorectal cancer (mCRC). Subgroup analysis of the PanaMa-study (AIO-KRK-0212).

ESMO open·2023
Same author

[Primary care medicine-Part II : Practice-oriented diagnosis and treatment pathways].

Der Internist·2021
Same author

[Endoscopic diagnosis, treatment, and follow-up of polyps of the upper gastrointestinal tract].

Der Internist·2020
Same author

[Monoclonal antibodies].

Der Internist·2019
Same author

[Pancreatic disorders : What is new?]

Der Internist·2019
Same author

ALIGNed on adherence: subanalysis of adherence in immune-mediated inflammatory diseases in the DACH region of the global ALIGN study.

Journal of the European Academy of Dermatology and Venereology : JEADV·2018
Same journal

Der Internist·2024
Same journal

Der Internist·2024
Same journal

Der Internist·2024
Same journal

Der Internist·2024
Same journal

Der Internist·2024
Same journal

Der Internist·2024
See all related articles

Area of Science:

  • Gastroenterology
  • Digestive Diseases
  • Medical Technology

Background:

  • Gastroesophageal reflux disease (GERD) is highly prevalent in industrialized nations, affecting 15-25% of adults.
  • Current treatments include proton pump inhibitors (PPIs) and antireflux surgery.
  • PPIs require lifelong adherence and do not restore the antireflux barrier, while surgery carries potential risks.

Purpose of the Study:

  • To evaluate endoscopic antireflux techniques as a potential third therapeutic option for GERD.
  • To address the lack of objective long-term data for endoluminal antireflux therapy.
  • To identify patient selection criteria for optimal benefit from endoscopic treatments.

Main Methods:

  • Review of existing literature on endoscopic antireflux procedures.

Related Experiment Videos

  • Analysis of available long-term outcome data for various endoscopic techniques.
  • Comparative assessment of endoscopic therapies versus PPIs and surgery.

    • Main Results:

    • Endoscopic antireflux techniques are emerging as a promising alternative to PPIs and surgery.
    • Objective long-term data are currently limited, hindering definitive conclusions.
    • Further research is required to establish efficacy and patient suitability.

    Conclusions:

    • Endoscopic antireflux therapies represent a developing area in GERD management.
    • More robust long-term studies are essential for clinical adoption and patient selection.
    • Identifying the right candidates will maximize the benefits of these novel treatments.